Presentations -
-
非小細胞肺癌における免疫チェックポイント阻害剤と細胞障害性抗癌薬との併用 Invited
森瀬昌宏
第60回日本呼吸器学会学術講演会 2020.9 一般社団法人日本呼吸器学会
-
肺癌に対する免疫療法の近未来的展望 放射線治療との併用 Invited
森瀬昌宏
第59回日本呼吸器学会学術講演会
-
小細胞肺癌をはじめとする肺神経内分泌腫瘍に対する治療～肺癌診療ガイドラインにおける治療推奨を踏まえて Invited
森瀬昌宏
第61回日本肺癌学会学術講演会 2020.11.25 特定非営利法人 日本肺癌学会
-
Does the histological differentiation of NSCLC affect the efficacy of immune checkpoint inhibitors?
Masahiro Morise, Sho Hori, Reiko Matsuzawa, Junji Koyama, Sachiko Ozone, Ichidai Tanaka, Tetsunari Hase, Koji Sakamoto, Shuichi Asano, Yasuhiro Kondoh, Naozumi Hashimoto
2020.11.26
-
The indication of primary prevention for febrile neutropenia (FN) in elderly NSCLC patients treated with docetaxel. International conference
Morise M, Kondo M, Hasegawa Y.
2016 the Japanese Society of Medical Oncology Annual Meeting
-
The efficacy and safety of re-challenge platinum plus pemtrexed combination therapy for recurrent malignant pleural mesothelioma International conference
Mariko Morishita, Masahiro Morise, Tetsunari Hase, Mitsuo Sato, Masashi Kondoh, Yoshinori Hasegawa.
16th World Conference on Lung Cancer
-
Clinicopathological analysis of SRE in patients with SCLC and NSCLC International conference
Morise M, Kondo M, Hasegawa Y
Japan Society of Medical Oncology Annual meeting 2015
-
The prophylactic antiemetic treatment failure in patients with lung cancer treated with CBDCA based-chemotherapy International conference
Ichikawa K, Morise M, Miyazaki M, Hase T, Kondo M, Hasegawa Y, Yamada K
Japan Society of Medical Oncology Annual meeting 2015
-
Can we predict serious adverse events (SAEs) and clarify unfit population for platinum-based chemotherapy in elderly patients (over 70 years of age) with advanced Non-small cell lung cancer (NSCLC)? (CJLSG 1203 trial) International conference
Kato T, Morise M, Ando M, Kojima E, Ogasawara T, Suzuki R, Shindo J, Matsumoto M, Sugino Y, Ogawa M, Nozaki Y, Kondo M, Saito H, Hasegawa Y.
European Society of Medical Oncology Annual meeting 2014
-
Clinicopathological analysis of long-term (more than 2 years) progression-free survivors treated with epidermal growth factor receptor - tyrosine kinase inhibitors (EGFR-TKIs) in patients with EGFR mutation-positive non-small cell lung cancer. International conference
Masahiro Morise, Koichi Goto, Shigeki Umemura, Shingo Matsumoto, Kiyotaka Yoh, Seiji Niho, Hironobu Ohmatsu, Kanji Nagai, Yuichiro Ohe.
15th World Conference on Lung Cancer
-
Final results of EGFR mutation reanalysis and KRAS mutation screening by Scorpion ARMS method: Phase II Study of Erlotinib for EGFR wild type Non-small cell Lung Cancer Patients. Central Japan Lung Study Group (CJLSG) 0903 trial. International conference
Eiichi Maruyama, Masahiro Morise, Tetsunari Hase, Hiroyuki Taniguchi, Hideo Saka, Joe Shindoh, Ryujiro Suzuki, Eiji Kojima, Kenji Ogawa, Takuya Ikeda, Yasuhiro Nozaki, Masahiko Ando, Masashi Kondo, Hiroshi Saito, Yoshinori Hasegawa.
15th World Conference on Lung Cancer
-
Phase II Study of Erlotinib for previously treated Non-small-cell Lung Cancer Patients without Epidermal Growth Factor Receptor Mutation: Central Japan Lung Study Group (CJLSG) 0903 trial International conference
Masahiro Morise, Hiroyuki Taniguchi, Hideo Saka, Joe Shindoh, Ryujiro Suzuki, Eiji Kojima, Tetsunari Hase, Masashi Kondo, Hiroshi Saito, Yoshinori Hasegawa.
-
高齢者非小細胞肺癌に対するプラチナ製剤併用療法に関する多施設共同後向き観察研究 （Central Japan Lung Study Group 1203試験）
田中健太郎、森瀬昌宏、安藤昌彦、加藤俊夫、小島英嗣、小笠原智彦、鈴木隆二郎、進藤丈、松本政実、杉野安輝、野﨑裕広、小川雅弘、長谷哲成、近藤征史、斉藤博、長谷川好規
第55回日本呼吸器学会学術講演会
-
再発小細胞肺癌に対しアムルビシン単剤療法を施行した患者の予後因子の検討
森瀬昌宏, 麻生裕紀, 長谷哲成, 若原恵子, 伊藤理, 橋本直純, 佐藤光夫, 近藤征史, 長谷川好規
第52回日本癌治療学会総会
-
EGFR-TKIにより2年以上の長期無増悪生存が得られるEGFR遺伝子変異陽性非小細胞肺癌の臨床病理学的検討
森瀬昌宏、後藤功一、梅村茂樹、松本慎吾、葉清隆、仁保誠治、大松広伸、永井完治、大江裕一郎
第54回日本肺癌学会総会
-
Capsaicinoids regulate airway anion transporters through Rho kinase- and cAMP-dependent mechanisms
-
再発小細胞肺癌に対する60mg/m2・3週投与1週休薬法によるイリノテカン単剤療法の検討 International conference
森瀬昌宏、仁保誠治、梅村茂樹、松本慎吾、葉清隆、後藤功一、大松広伸、大江裕一郎
第53回日本肺癌学会総会
-
Prognostic Factors in Recurrent Small Cell Lung Carcinoma International conference
Masahiro Morise, Takefumi Mizutani, Tomoyo Oguri, Naoyuki Imai, Tetsunari Hase, Yuichiro Shindo, Yoshihiro Inukai, Satoru Ito, Naozumi Hashimoto, Mitsuo Sato, Masashi Kondo, Yoshinori Hasegawa.
Japan Society of Medical Oncology Annual meeting
-
Prospective Analysis of Efficacy and Safety of Individualized Administration of Midazolam for Sedation During Bronchoscopy International conference
Imaizumi K, Hashimoto I, Shindo Y, Imai N, Ogawa T, Morise M, Ito S, Hashimoto N, Sato M, Kondo M, Hasegawa Y
CHEST 2011
-
ヒト気道上皮のイオン輸送体に対するmentholの細胞骨格を介した制御 International conference
森瀬昌宏、伊藤康、日比野佳孝、伊藤理、橋本直純、近藤征史、今泉和良、長谷川好規
アレルギー学会総会秋季大会
-
Efficacy in the elderly NSCLC patients in SCORPION study: Phase II study of DTX plus RAM following platinum-based chemotherapy plus ICIs International conference
Yamaguchi, T; Matsuzawa, R; Morise, M; Ito, K; Hataji, O; Takahashi, K; Koyama, J; Kuwatsuka, Y; Goto, Y; Imaizumi, K; Itani, H; Zenke, Y; Oki, M; Ishii, M
ANNALS OF ONCOLOGY 2023.11
-
Multi-center, phase II study of docetaxel (DTX) plus ramucirumab (RAM) following platinum-based chemotherapy plus ICIs in patients with NSCLC: SCORPION study International conference
Matsuzawa, R; Morise, M; Ito, K; Hataji, O; Takahashi, K; Kuwatsuka, Y; Goto, Y; Imaizumi, K; Itani, H; Yamaguchi, T; Zenke, Y; Oki, M; Ishii, M
JOURNAL OF THORACIC ONCOLOGY 2023.4
-
CLIP1-LTK: a novel target in non-small cell lung cancer International conference
Izumi, H; Matsumoto, S; Mori, S; Hayashi, K; Watanabe, K; Fukuhara, T; Shibata, Y; Yoh, K; Morise, M; Toyozawa, R; Chikamori, K; Miyamoto, S; Asano, S; Shingyoji, M; Nakao, M; Azuma, K; Niho, S; Ishii, G; Kobayashi, SS; Goto, K
ANNALS OF ONCOLOGY 2022.7
-
Tepotinib in Asian patients with advanced NSCLC with MET exon 14 (METex14) skipping. International coauthorship International conference
Kato, T; Yang, JCH; Ahn, MJ; Sakai, H; Morise, M; Chen, YM; Han, JY; Yang, JJ; Zhao, J; Huang, J; Berghoff, K; Bruns, R; Vioix, H; Otto, G; Le, X; Paik, PK
JOURNAL OF CLINICAL ONCOLOGY 2022.6.1
-
Study Design of SCORPION: Multi-Center, Phase II Study Following Platinum-Based Chemotherapy Plus ICIs in Patients with NSCLC International conference
Matsuzawa, R; Morise, M; Ito, K; Hataji, O; Takahashi, K; Hara, T; Goto, Y; Imaizumi, K; Itani, H; Yamaguchi, T; Zenke, Y; Oki, M; Kogure, Y; Hashimoto, N
JOURNAL OF THORACIC ONCOLOGY 2021.10
-
Phase II Trial of Antiemetic Oral Granisetron Plus Dexamethasone for Nausea and Vomiting Caused by Crizotinib in ALK or ROS1 Fusion-Positive NSCLC International conference
Kawasumi, K; Morise, M; Kirita, K; Saeki, K; Kameoka, H; Daga, H; Miyazaki, M; Toyozawa, R; Uoi, M; Harada, M; Tamaki, S; Takeda, M; Fujiwara, K; Yamanaka, T; Goto, K
JOURNAL OF THORACIC ONCOLOGY 2021.10
-
Tepotinib safety in MET exon 14 (METex14) skipping NSCLC: Updated results from the VISION trial International coauthorship International conference
Morise, M; Sakai, H; Veillon, R; Le, XN; Felip, E; Garassino, MC; Cortot, AB; Smit, E; Park, K; Griesinger, F; Britschgi, C; Wu, YL; Berghoff, K; Otto, G; Bruns, R; Paik, P
ANNALS OF ONCOLOGY 2021.7
-
Weekly nab-PTX and weekly PTX for relapsed small cell lung cancer International conference
Oi, H; Yamano, Y; Yokoyama, T; Matsuda, T; Morise, M; Kataoka, K; Kimura, T; Kondoh, Y
ANNALS OF ONCOLOGY 2019.11
-
Serum CRP Decrease Has Predictive Value for LongTerm Disease Control by PD-1/ PD-L1 Inhibitors in Patients with NSCLC International conference
Matsuzawa, R; Morise, M; Tanaka, I; Koyama, J; Kimura, T; Kondoh, Y; Hase, T; Sakamoto, K; Hashimoto, N; Hasegawa, Y
JOURNAL OF THORACIC ONCOLOGY 2019.10
-
A nationwide genomic screening project for small cell lung cancer in Japan (LC-SCRUM-Japan) International conference
Daga, H; Umemura, S; Ohe, Y; Shiota, T; Fujita, M; Furuya, N; Tsuda, T; Morise, M; Matsumoto, S; Goto, K
ANNALS OF ONCOLOGY 2017.10
-
Comparison of the incidence of skeletal related events (SREs) between non small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) International conference
Morise, M; Kondo, M; Hasegawa, Y
ANNALS OF ONCOLOGY 2015.12
-
The Efficacy and Safety of Re-Challenge Platinum plus Pemetrexed Combination Therapy for Recurrent Malignant Pleural Mesothelioma International conference
Morishita, M; Morise, M; Hase, T; Sato, M; Kondoh, M; Hasegawa, Y
JOURNAL OF THORACIC ONCOLOGY 2015.9
-
PHASE II STUDY OF ERLOTINIB FOR PREVIOUSLY TREATED NON-SMALL CELL LUNG CANCER PATIENTS WITHOUT EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION: CENTRAL JAPAN LUNG STUDY GROUP (CJLSG) 0903 TRIAL International conference
Morise, M; Taniguchi, H; Saka, H; Shindoh, J; Suzuki, R; Kojima, E; Hase, T; Kondo, M; Saito, H; Hasegawa, Y
ANNALS OF ONCOLOGY 2012.9
-
IMpower110: Interim overall survival (OS) analysis of a phase III study of atezolizumab (atezo) vs platinum-based chemotherapy (chemo) as first-line (1L) treatment (tx) in PD-L1-selected NSCLC International coauthorship International conference
Spigel D., de Marinis F., Giaccone G., Reinmuth N., Vergnenegre A., Barrios C. H., Morise M., Felip E., Andric Z. G., Geater S., Ozguroglu M., Mocci S., McCleland M., Enquist I., Komatsubara K. M., Deng Y., Kuriki H., Wen X., Jassem J., Herbst R. S.
ANNALS OF ONCOLOGY 2019.10
-
外来肺癌治療の現状と課題 Invited
森瀬 昌宏
日本呼吸ケア・リハビリテーション学会誌 2018.10.15 一般社団法人 日本呼吸ケア・リハビリテーション学会
-
P12-2 高齢者におけるEBUS-TBNAの検討(EBUS3,ポスター12,第35回日本呼吸器内視鏡学会学術集会)
岡地 祥太郎, 今井 直幸, 伊藤 亮太, 小林 大介, 木村 元宏, 村田 直彦, 深津 明日樹, 高嶋 浩司, 梶川 茂久, 丸山 英一, 麻生 裕紀, 進藤 有一郎, 青山 大輔, 森瀬 昌宏, 佐藤 光夫, 近藤 征史, 長谷川 好規, 橋本 泉, 今泉 和良
気管支学 2012 特定非営利活動法人 日本呼吸器内視鏡学会
-
P11-4 当院でEBUS-TBNAを施行し,偽陰性診断であった5症例の検討(EBUS2,ポスター11,第35回日本呼吸器内視鏡学会学術集会)
麻生 裕紀, 今井 直幸, 橋本 泉, 今泉 和良, 魚津 桜子, 田中 一大, 青山 大輔, 伊藤 亮太, 小林 大介, 村田 直彦, 高嶋 浩司, 岡地 祥太郎, 丸山 英一, 深津 明日樹, 木村 元宏, 梶川 茂久, 進藤 有一郎, 森瀬 昌宏, 犬飼 朗博, 佐藤 光夫, 近藤 征史, 長谷川 好規
気管支学 2012 特定非営利活動法人 日本呼吸器内視鏡学会
-
P10-5 超音波気管支鏡(EBUS-TBNA)で診断した肺過誤腫の一例(EBUS1,ポスター10,第35回日本呼吸器内視鏡学会学術集会)
梶川 茂久, 今井 直幸, 麻生 裕紀, 伊藤 亮太, 犬飼 朗博, 青山 大輔, 岡地 祥太郎, 木村 元宏, 小林 大介, 近藤 征史, 佐藤 光夫, 進藤 有一郎, 深津 明日樹, 丸山 英一, 村田 直彦, 森瀬 昌宏, 高嶋 浩司, 橋本 泉, 今泉 和良, 長谷川 好規
気管支学 2012 特定非営利活動法人 日本呼吸器内視鏡学会
-
Japanese Journal of Allergology 2013 Japanese Society of Allergology
-
P10-3 悪性腫瘍との鑑別を要し, EBUS-TBNA施行した縦隔内副甲状腺嚢胞の一例(EBUS1,ポスター10,第35回日本呼吸器内視鏡学会学術集会)
高嶋 浩司, 今井 直幸, 伊藤 亮太, 小林 大介, 村田 直彦, 深津 明日樹, 梶川 茂久, 岡地 祥太郎, 丸山 英一, 麻生 裕紀, 青山 大輔, 森瀬 昌宏, 進藤 有一郎, 橋本 泉, 犬飼 朗博, 橋本 直純, 佐藤 光夫, 近藤 征史, 今泉 和良, 長谷川 好規
気管支学 2012 特定非営利活動法人 日本呼吸器内視鏡学会
-
6.EBUS-TBNAが診断に有用であった子宮頸癌肺転移の1例(第40回 日本呼吸器内視鏡学会中部支部会)
橋本 泉, 今井 直幸, 犬飼 朗博, 岩木 舞, 下方 智也, 森瀬 昌宏, 小川 知美, 山下 良, 田中 一大, 橋本 直純, 佐藤 光夫, 近藤 征史, 今泉 和良, 長谷川 好規
気管支学 2011 特定非営利活動法人 日本呼吸器内視鏡学会
-
Real-world evidence of crizotinib for ROS1-tested patients with non-small cell lung cancer in Japan International conference
Morise, M
ANNALS OF ONCOLOGY 2022.7
-
Hase, T; Yanagisawa, K; Fukatsu, A; Kimura, T; Kojima, E; Abe, T; Imaizumi, K; Horio, Y; Oguri, T; Yamamoto, M; Ogasawara, T; Sugino, Y; Morise, M; Nakatochi, M; Ando, M; Kondo, M; Saka, H; Saito, H; Hasegawa, Y; Takahashi, T
JOURNAL OF CLINICAL ONCOLOGY 2020.5.20
-
Impact of Combined Evaluation Using Tumor Volume and Metastatic Nodal Extent in Stage III NSCLC Treated with CRT International conference
Tamiya, Y; Morise, M; Matsuzawa, R; Tanaka, I; Okada, T; Iwano, S; Hase, T; Hashimoto, N; Sato, M; Itoh, Y; Hasegawa, Y
JOURNAL OF THORACIC ONCOLOGY 2019.10
-
Alectinib in Previously Treated RET-Rearranged Advanced Non-Small-Cell Lung Cancer: A Phase 1/2 Trial (ALL-RET) International conference
Yanagitani, N; Takeuchi, S; Murayama, T; Yoshimura, K; Imai, Y; Takahara, S; Kawakami, T; Seto, T; Hattori, Y; Ohashi, K; Morise, M; Matsumoto, S; Yoh, K; Goto, K; Nishio, M; Yano, S
JOURNAL OF THORACIC ONCOLOGY 2019.10
-
Immune checkpoint inhibitor for advanced or recurrent non-small cell lung cancer patients with poor performance status International conference
Koyama, J; Kimura, T; Oi, H; Yamano, Y; Yokoyama, T; Matsuda, T; Kataoka, K; Matsuzawa, R; Fukihara, J; Sakamoto, K; Morise, M; Hashimoto, N; Kondoh, Y; Hasegawa, Y
ANNALS OF ONCOLOGY 2019.10
-
A PHASE II TRIAL OF ERLOTINIB FOR PREVIOUSLY TREATED JAPANESE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER HARBORING EGFR MUTATIONS: RESULTS OF THE CENTRAL JAPAN LUNG STUDY GROUP TRIAL (CJLSG0904). International conference
Hase, T; Morise, M; Taniguchi, H; Shindoh, J; Kojima, E; Tanikawa, Y; Suzuki, R; Ogasawara, T; Yamada, Y; Ando, M; Kondo, M; Saito, H; Hasegawa, Y
JOURNAL OF THORACIC ONCOLOGY 2013.11
-
PROGNOSTIC FACTORS IN RECURRENT SMALL-CELL LUNG CARCINOMA International conference
Morise, M; Mizutani, T; Oguri, T; Imai, N; Hase, T; Shindo, Y; Inukai, Y; Ito, S; Hashimoto, N; Sato, M; Kondo, M; Hasegawa, Y
ANNALS OF ONCOLOGY 2012.10
-
Activity of tepotinib in brain metastases (BM): Preclinical models and clinical data from patients (pts) with MET exon 14 (METex14) skipping NSCLC International coauthorship International conference
Viteri S., Mazieres J., Veillon R., Felip E., Le X., Garassino M. C., Stanton T. S., Morise M., Lee J-S., Matsumoto S., De Marinis F., Wehler T., Clark A., Friese-Hamim M., Stroh C., Bruns R., Otto G., Paik P. K.
ANNALS OF ONCOLOGY 2020.9
-
Alectinib in Previously Treated RET-Rearranged Advanced Non-Small-Cell Lung Cancer: A Phase 1/2 Trial (ALL-RET) International conference
Yanagitani N., Takeuchi S., Murayama T., Yoshimura K., Imai Y., Takahara S., Kawakami T., Seto T., Hattori Y., Ohashi K., Morise M., Matsumoto S., Yoh K., Goto K., Nishio M., Yano S.
JOURNAL OF THORACIC ONCOLOGY 2019.10
-
A nationwide genomic screening project for small cell lung cancer in Japan (LC-SCRUM-Japan) International conference
Daga Haruko, Umemura Shigeki, Ohe Yuichiro, Shiota Tetsuhiro, Fujita Masaki, Furuya Naoki, Tsuda Takeshi, Morise Masahiro, Matsumoto Shingo, Goto Koichi
ANNALS OF ONCOLOGY 2017.10
-
Weekly nab-PTX and weekly PTX for relapsed small cell lung cancer International conference
Oi H., Yamano Y., Yokoyama T., Matsuda T., Morise M., Kataoka K., Kimura T., Kondoh Y.
ANNALS OF ONCOLOGY 2019.11
-
UHRF1 as a Potential Therapeutic Target for KRAS Mutated Non-Small Cell Lung Cancer International conference
Goto D., Kizuki M., Uwatoko N., Kawai K., Koike M., Nakashima M., Miyazawa A., Tanaka I., Hase T., Morise M., Hasegawa Y., Minna J., Sato M.
JOURNAL OF THORACIC ONCOLOGY 2019.10
-
The Subunit eIF2 ss of Translation- Initiation Factor EIF2 Is a Potential Therapeutic Target for Non-Small Cell Lung Cancer International conference
Sato Mitsuo, Tanaka Ichidai, Goto Daiki, Kato Toshio, Kakumu Tomohiko, Miyazawa Ayako, Yogo Naoyuki, Hase Tetsunari, Morise Masahiro, Sekido Yoshitaka, Kondo Masashi, Hasegawa Yoshinori
CANCER SCIENCE 2018.12
-
Tepotinib in Patients with Advanced NSCLC with MET Exon 14 (METex14) Skipping: Overall Efficacy Results from VISION Cohort A International coauthorship International conference
Mazieres J., Paik P., Felip E., Veillon R., Sakai H., Cortot A., Viteri S., Garassino M., Van Meerbeeck J., Raskin J., Thomas M., Morise M., Cho B. C., Conte P., Bruns R., Demuth T., Schumacher K. M., Le X.
JOURNAL OF THORACIC ONCOLOGY 2021.1
-
Tepotinib in patients with advanced non-small lung cancer (NSCLC) and MET exon 14-skipping mutations: Phase II data International coauthorship International conference
Sakai H., Felip E., Cortot A. B., Veillon R., Griesinger F., Patel J., Horn L., Mazieres J., De Castro Carpeno J., Morise M., Sakamoto T., Bruns R., Scheele J., Straub J., Paik P.
ANNALS OF ONCOLOGY 2018.11
-
Tepotinib in patients (pts) with advanced NSCLC with MET exon 14 (METex14) skipping: Overall efficacy results from VISION cohort A International coauthorship International conference
Mazieres J., Paik P. K., Felip E., Veillon R., Sakai H., Cortot A. B., Viteri S., Garassino M. C., Van Meerbeeck J. P., Raskin J., Thomas M., Morise M., Cho B. C., Conte P., Bruns R., Demuth T., Schumacher K. M., Le X.
ANNALS OF ONCOLOGY 2020.9
-
Tepotinib in NSCLC patients with METex14 mutations: interim results from the phase II VISION study International coauthorship International conference
Sakai Hiroshi, Veillon Remi, Cortot Alexis B., Felip Enriqueta, Mazieres Julien, Morise Masahiro, Sakamoto Tomohiro, Tokito Takaaki, Atagi Shinji, Kato Terufumi, Kumagai Toru, Tanaka Hiroshi, Bruns Rolf, Straub Josef, Scheele Juergen, Le Xiuning, Paik Paul K.
ANNALS OF ONCOLOGY 2019.10
-
Tepotinib in NSCLC patients harboring METex14 skipping: Cohort A of phase II VISION study International conference
Park K., Felip E., Veillon R., Cortot A., Mazieres J., Sakai H., Reinmuth N., Viteri S., Chen Y-M., Han J-Y., Jang T-W., Morise M., Sakamoto T., Tokito T., Cho B. C., Bruns R., Scheele J., Straub J., Le X., Paik P. K.
ANNALS OF ONCOLOGY 2019.11
-
Tepotinib in Asian patients (pts) with advanced NSCLC with MET exon 14 (METex14) skipping International coauthorship International conference
Yang J. C-H., Le X., Cho B. C., Han J-Y., Morise M., Chen Y-M., Kang J-H., Kato T., Takeoka H., Chikamori K., Sakai H., Park K., Wu Y-L., Schumacher K., Bruns R., Straub J., Paik P.
ANNALS OF ONCOLOGY 2020.11
-
Tepotinib Activity in Brain Metastases (BM): Preclinical Models and Clinical Data from MET Exon 14 (METex14) Skipping NSCLC International coauthorship International conference
Viteri S., Mazieres J., Veillon R., Felip E., Le X., Garassino M., Stanton T., Morise M., Lee J. -S., Matsumoto S., De Marinis F., Wehler T., Clark A., Friese-Hamim M., Stroh C., Bruns R., Otto G., Paik P.
JOURNAL OF THORACIC ONCOLOGY 2021.1
-
Short Hydration Regimen with a Modified Dose of Magnesium Supplementation for Lung Cancer Patients Receiving Cisplatin-Based Chemotherapy International conference
Hase T., Miyazaki M., Ichikawa K., Yogo N., Ozawa N., Ando M., Morise M., Sato M., Kondo M., Yamada K., Hasegawa Y.
JOURNAL OF THORACIC ONCOLOGY 2018.10
-
Serum CRP Decrease Has Predictive Value for LongTerm Disease Control by PD-1/ PD-L1 Inhibitors in Patients with NSCLC International conference
Matsuzawa R., Morise M., Tanaka I., Koyama J., Kimura T., Kondoh Y., Hase T., Sakamoto K., Hashimoto N., Hasegawa Y.
JOURNAL OF THORACIC ONCOLOGY 2019.10
-
Risk Factor Evaluation of Programmed Death 1 Inhibitor Related Pneumonitis in Patients with Non-Small Cell Lung Cancer International conference
Fukihara J., Sakamoto K., Iwano S., Morise M., Hashimoto N., Hasegawa Y.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2018
-
PREDICT1: An observational study for identifying blood biomarkers associated with clinical benefit from carboplatin and pemetrexed (CbP) treatment in patients with non-squamous (NS) non-small cell lung cancer (NSCLC) (CJLSG1201). International conference
Hase Tetsunari, Yanagisawa Kiyoshi, Fukatsu Asuki, Kimura Tomoki, Kojima Eiji, Abe Takashi, Imaizumi Kazuyoshi, Horio Yoshitsugu, Oguri Tetsuya, Yamamoto Masashi, Ogasawara Tomohiko, Sugino Yasuteru, Morise Masahiro, Nakatochi Masahiro, Ando Masahiko, Kondo Masashi, Saka Hideo, Saito Hiroshi, Hasegawa Yoshinori, Takahashi Takashi
JOURNAL OF CLINICAL ONCOLOGY 2020.5.20
-
Phase II study of tepotinib in NSCLC patients with METex14 mutations. International coauthorship International conference
Paik Paul K., Veillon Remi, Cortot Alexis B., Felip Enriqueta, Sakai Hiroshi, Mazieres Julien, Griesinger Frank, Horn Leora, Senellart Helene, Van Meerbeeck Jan P., de Castro Carpeno Javier, Patel Jyoti D., Garassino Marina Chiara, Morise Masahiro, Reinmuth Niels, Viteri Santiago, Tokito Takaaki, Sakamoto Tomohiro, Scheele Juergen, Le Xiuning
JOURNAL OF CLINICAL ONCOLOGY 2019.5.20
-
Phase II study of gedatolisib for small-cell lung cancer (SCLC) patients (pts) with genetic alterations in PI3K/AKT/mTOR pathway based on a large-scale nationwide genomic screening network in Japan (EAGLE-PAT/LC-SCRUM-Japan). International conference
Udagawa Hibiki, Ikeda Takaya, Umemura Shigeki, Daga Haruko, Toyozawa Ryo, Harada Daijiro, Sakakibara-Konishi Jun, Morise Masahiro, Yamamoto Noboru, Takahashi Toshiaki, Kato Terufumi, Shingyoji Masato, Ushio Ryota, Hara Satoshi, Takata Saori, Nomura Shogo, Matsumoto Shingo, Niho Seiji, Sato Akihiro, Goto Koichi
JOURNAL OF CLINICAL ONCOLOGY 2020.5.20
-
Phase II study of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study International conference
Shimokawa M., Nosaki K., Seto T., Ohashi K., Morise M., Fujiwara Y., Sakakibara J., Murakami H., Yano S., Satouchi M., Matsumoto S., Goto K., Yoh K.
ANNALS OF ONCOLOGY 2019.4
-
IMPOWER110: INTERIM OVERALL SURVIVAL (OS) ANALYSIS OF A PHASE III STUDY OF ATEZOLIZUMAB (ATEZO) MONOTHERAPY VS PLATINUM-BASED CHEMOTHERAPY (CHEMO) AS FIRST-LINE (1L) TREATMENT IN PD-L1-SELECTED NSCLC International coauthorship International conference
Herbst Roy, De Marinis Filippo, Giaccone Giuseppe, Reinmuth Niels, Vergnenegre Alain, Barrios Carlos, Morise Masahiro, Font Enriqueta, Andric Zoran, Geater Sarayut, Ozguroglu Mustafa, Mocci Simonetta, McCleland Mark, Enquist Ida, Komatsubara Kim, Deng Yu, Kuriki Hiroshi, Wen Xiaohui, Jassem Jacek, Spigel David
JOURNAL FOR IMMUNOTHERAPY OF CANCER 2020.4
-
Impower110: Interim OS Analysis of a Phase III Study Of Atezolizumab (ATEZO) vs Platinum-Based Chemotherapy (Chemo) as 1L Treatment (TX) in PD-L1-Selected NSCLC International coauthorship International conference
Reinmuth Niels, Spigel David, De Marinis Filippo, Giaccone Giuseppe, Verynenegre Alain, Barrios Carlos Henrique, Morise Masahiro, Felip Enriqueta, Andric Zoran, Geater Sarayut, Ozgueroglur Mustafa, Mocci Simonetta, Mccleland Mark, Enquist Ida, Kotnatsubara Kim, Deng Yu, Kuriki Hiroshi, Wen Xiaohui, Jassem Jacek, Herbst Roy S.
ONCOLOGY RESEARCH AND TREATMENT 2020.2
-
Impact Of Mild To Moderate COPD On Prognosis And Feasibility For Chemotherapy In Patients With Lung Cancer
Omote N., Hashimoto N., Morise M., Miyazaki S., Ando A., Hasegawa Y.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 2017
-
Impact of Combined Evaluation Using Tumor Volume and Metastatic Nodal Extent in Stage III NSCLC Treated with CRT International conference
Tamiya Y., Morise M., Matsuzawa R., Tanaka I., Okada T., Iwano S., Hase T., Hashimoto N., Sato M., Itoh Y., Hasegawa Y.
JOURNAL OF THORACIC ONCOLOGY 2019.10
-
Immune checkpoint inhibitor for advanced or recurrent non-small cell lung cancer patients with poor performance status International conference
Koyama Junji, Kimura Tomoki, Oi Hajime, Yamano Yasuhiko, Yokoyama Toshiki, Matsuda Toshiaki, Kataoka Kensuke, Matsuzawa Reiko, Fukihara Jun, Sakamoto Koji, Morise Masahiro, Hashimoto Naozumi, Kondoh Yasuhiro, Hasegawa Yoshinori
ANNALS OF ONCOLOGY 2019.10
-
Identification of Proteosomal Catalytic Subunit PSMA6 as a Therapeutic Target for Lung Cancer through a Pooled shRNA Screen International conference
Sato M., Kakumu T., Goto D., Kato T., Yogo N., Hase T., Morise M., Fukui T., Yokoi K., Sekido Y., Girard L., Minna J., Byers L., Heymach J., Coombes K., Kondo M., Hasegawa Y.
JOURNAL OF THORACIC ONCOLOGY 2017.11
-
Final PFS analysis and safety data from the phase III J-ALEX study of alectinib (ALC) vs. crizotinib (CRZ) in ALK-inhibitor naive ALK-positive non-small cell lung cancer (ALK plus NSCLC). International conference
Seto Takashi, Nishio Makoto, Hida Toyoaki, Nokihara Hiroshi, Morise Masahiro, Kim Young Hak, Azuma Koichi, Takiguchi Yuichi, Yoshioka Hiroshige, Kumagai Toru, Hotta Katsuyuki, Watanabe Satoshi, Goto Koichi, Satouchi Miyako, Kozuki Toshiyuki, Nakagawa Kazuhiko, Mitsudomi Tetsuya, Yamamoto Nobuyuki, Asakawa Takashi, Tamura Tomohide
JOURNAL OF CLINICAL ONCOLOGY 2019.5.20
-
eIF2 beta, A Subunit of Translation-Initiation Factor EIF2, as a Potential Therapeutic Target for Non-Small Cell Lung Cancer International conference
Goto D., Tanaka I., Sato M., Kato T., Miyazawa A., Hase T., Morise M., Sekido Y., Girard L., Minna J., Byers L., Heymach J., Coombes K., Kondo M., Hasegawa Y.
JOURNAL OF THORACIC ONCOLOGY 2018.10
-
Clinicopathological Significance of Cancer Stem-Like Cell Markers in High-Grade Neuroendocrine Carcinoma of the Lung International conference
Morise Masahiro, Hishida Tomoyuki, Takahashi Akiko, Yoshida Junji, Ohe Yuichiro, Nagai Kanji, Ishii Genichiro
JOURNAL OF THORACIC ONCOLOGY 2017.1
-
Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by SP142, SP263 and 22C3 PD-L1 immunohistochemistry (IHC) assays and by blood tumour mutational burden (bTMB): Results from the IMpower110 study International coauthorship International conference
Herbst R. S., de Marinis F., Giaccone G., Reinmuth N., Vergnenegre A., Barrios C. H., Morise M., Felip E., Andric Z., Geater S., Ozguroglu M., Mocci S., McCleland M., Zou W., Enquist I., Komatsubara K., Deng Y., Kuriki H., Spigel D. R., Jassem J.
ANNALS OF ONCOLOGY 2019.12
-
Clinical efficacy of atezolizumab (atezo) in biomarker subgroups by PD-L1 immunohistochemistry (IHC) assays and blood tumour mutational burden (bTMB): IMpower110 International coauthorship International conference
Herbst R. S., De Marinis F., Giaccone G., Stahel R., Reinmuth N., Vergnenegre A., Barrios C. H., Morise M., Felip E., Andric Z., Geater S., Ozguroglu M., Mocci S., McCleland M., Zou W., Enquist I., Komatsubara K., Deng Y., Kuriki H., Spigel D., Jassem J.
SWISS MEDICAL WEEKLY 2020.11.18
-
Alectinib in Previously Treated RET-Rearranged Advanced Non-Small-Cell Lung Cancer: A Phase 1/2 Trial (ALL-RET) International conference
Yanagitani N., Takeuchi S., Murayama T., Yoshimura K., Imai Y., Takahara S., Kawakami T., Seto T., Hattori Y., Ohashi K., Morise M., Matsumoto S., Yoh K., Goto K., Nishio M., Yano S.
JOURNAL OF THORACIC ONCOLOGY 2019.10
-
Activity of tepotinib in brain metastases (BM): Preclinical models and clinical data from patients (pts) with MET exon 14 (METex14) skipping NSCLC International coauthorship International conference
Viteri S., Mazieres J., Veillon R., Felip E., Le X., Garassino M. C., Stanton T. S., Morise M., Lee J-S., Matsumoto S., De Marinis F., Wehler T., Clark A., Friese-Hamim M., Stroh C., Bruns R., Otto G., Paik P. K.
ANNALS OF ONCOLOGY 2020.9
-
6.EBUS-TBNAが診断に有用であったHodgkinリンパ腫の1例(第39回 日本呼吸器内視鏡学会中部支部会)
飛田 理世, 小栗 知世, 森瀬 昌宏, 今井 直幸, 橋本 泉, 橋本 直純, 佐藤 光男, 近藤 征史, 今泉 和良, 長谷川 好規
気管支学 2010 特定非営利活動法人 日本呼吸器内視鏡学会
-
2.著明な気管内病変を呈したmalignant fibrous histiocytoma(MFH)肺転移の1例(第41回 日本呼吸器内視鏡学会中部支部会)
呂 成九, 岡地 祥太郎, 今井 直幸, 橋本 泉, 長谷 哲也, 進藤 有一郎, 森瀬 昌宏, 橋本 直純, 佐藤 光夫, 近藤 征史, 今泉 和良, 長谷川 好規
気管支学 2011 特定非営利活動法人 日本呼吸器内視鏡学会
-
21-7-O14-08 高齢者肺癌カルボプラチン併用療法における悪心・嘔吐のリスク因子の検討(がん薬物療法(副作用対策),口頭発表,一般演題,医療薬学の進歩と未来-次の四半世紀に向けて-)
市川 和哉, 森瀬 昌宏, 宮崎 雅之, 亀島 理沙, 長谷 哲成, 近藤 征史, 長谷川 好規, 山田 清文
日本医療薬学会年会講演要旨集 2015.10.23 一般社団法人 日本医療薬学会